Sort by:

Filter by:
Number of comments

Displaying results 41 - 60 of 102 for "Humanity".

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

Determination of Regulatory Review Period for Purposes of Patent Extension; SYMDEKO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for SYMDEKO and is publishing this notice of that determination as required by law. FDA …

Live Biotherapeutic Products To Prevent Necrotizing Enterocolitis in Very Low Birth Weight Infants; Public Workshop; Request for Comments

The Food and Drug Administration FDA or Agency the Centers for Disease Control and Prevention CDC the National Institutes of Health NIH the National Institute of Allergy and Infectious Diseases …

Determination of Regulatory Review Period for Purposes of Patent Extension; REZLIDHIA

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for REZLIDHIA and is publishing this notice of that determination as required by law. FDA …

Request for Public Comment on the Draft Hazard Review: Wildland Fire Smoke Exposure Among Farmworkers and Other Outdoor Workers

The National Institute for Occupational Safety and Health NIOSH in the Centers for Disease Control and Prevention CDC an Operating Division of the Department of Health and Human Services HHS …

Risk Evaluations for Chemical Substances

The Environmental Protection Agency EPA or Agency is announcing the availability of and seeking public comment on a draft risk evaluation under the Toxic Substances Control Act TSCA for di-isononyl …

Agency Information Collection Activities; Proposals, Submissions, and Approvals

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

Advancing Smoking Cessation: Food and Drug Administration and National Institutes of Health Priorities; Public Meeting; Request for Comments

The Food and Drug Administration FDA the Agency or we is announcing the following public meeting entitled Advancing Smoking Cessation: FDA and NIH Priorities. Jointly convened by FDA and the …

End Stage Renal Disease Annual Facility Survey Form (CMS-2744)

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

Agency Information Collection Activities; Proposals, Submissions, and Approvals

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

Agency Information Collection Activities; Proposed Collection; Comment Request; Laboratory Accreditation for Analyses of Foods

The Food and Drug Administration FDA or Agency is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act …

Agency Information Collection Activities; Proposals, Submissions, and Approvals

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

Identifying Priority Focus Areas for Future Guidance Development and Engagement With Interested Parties in Model-Informed Drug Development; Request for Information

The Center for Drug Evaluation and Research CDER and Center for Biologics Evaluation and Research CBER within the Food and Drug Administration FDA or Agency are announcing a request for …

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Yale-Mayo Clinic Centers of Excellence in Regulatory Science and Innovation B12 Pediatric Device Survey

The Food and Drug Administration FDA or we is announcing that a proposed collection of information has been submitted to the Office of Management and Budget OMB for review and …

Agency Information Collection Activities; Proposed Collection; Comment Request; Obtaining Information To Understand Challenges and Opportunities Encountered by Compounding Outsourcing Facilities

The Food and Drug Administration FDA Agency or we is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction …

Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution and Related Collections of Information

The Food and Drug Administration FDA the Agency or we is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork …